Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Cryptococcus neoformans Chemotyping by Quantitative Analysis of 1H Nuclear Magnetic Resonance Spectra of Glucuronoxylomannans with a Computer-Simulated Artificial Neural Network
- R. Cherniak, H. Valafar, L. C. Morris, F. Valafar
- Chemistry, Medicine
- Clinical Diagnostic Laboratory Immunology
- 1 March 1998
ABSTRACT The complete assignment of the proton chemical shifts obtained by nuclear magnetic resonance (NMR) spectroscopy of de-O-acetylated glucuronoxylomannans (GXMs) from Cryptococcus… Expand
Microevolution of a Standard Strain ofCryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes
- S. Franzot, J. Mukherjee, R. Cherniak, L. Chen, J. S. Hamdan, A. Casadevall
- Biology, Medicine
- Infection and Immunity
- 1 January 1998
ABSTRACT Cryptococcus neoformans is a major fungal pathogen for patients with debilitated immune systems. However, no information is available on the stability of virulence or of phenotypes… Expand
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
- R. Cherniak, J. B. Sundstrom
- Biology, Medicine
- Infection and immunity
- 1 May 1994
The major significance of the capsular polysaccharide of C. neoformans is its role in potentiating opportunistic infections by the yeast. It has the ability to exert a broad spectrum of influences on… Expand
A galactoxylomannan antigen of Cryptococcus neoformans serotype A
- R. Cherniak, E. Reiss, S. H. Turner
- Chemistry
- 16 May 1982
Abstract The capsular polysaccharide of Cryptococcus neoformans serotype A was fractionated into two chemically and serologically distinct heteroglycans by differential precipitation with… Expand
Cell-wall glucans of Cryptococcus neoformans Cap 67.
- P. James, R. Cherniak, R. Jones, C. A. Stortz, E. Reiss
- Chemistry, Medicine
- Carbohydrate research
- 2 April 1990
Purified cell walls derived from Cryptococcus neofromans Cap 67, an acapsular mutant, consisted of 86% Glc and 7.3% GlcNAc. The integrity of the cell walls was disrupted in three successive… Expand
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
- V. V. Vaishnav, B. E. Bacon, M. O'Neill, R. Cherniak
- Chemistry, Medicine
- Carbohydrate research
- 1998
The galactoxylomannan (GalXM) obtained from the culture supernatant of an acapsular mutant of Cryptococcus neoformans Cap67 was purified by Concanavalin A affinity, ion-exchange, and gel-filtration… Expand
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
- R. Cherniak, E. Reiss, M. Slodki, R. Plattner, S. Blumer
- Biology, Medicine
- Molecular immunology
- 1 August 1980
Abstract The glucuronoxylomannan (GXM) of C. neoformans serotype A contained molar ratios of xylose: mannose: glucuronic acid: O -acetyl of 2:5:1:2. The xylose and glucuronic acid occurred as single… Expand
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
- W. Chaka, A. Verheul, +5 authors A. Hoepelman
- Biology, Medicine
- Journal of immunology
- 15 September 1997
We have shown previously that specific receptors on PBMCs and a serum factor other than Ab and complement are involved in the TNF-alpha response to cryptococcal mannoprotein (MP2). To characterize… Expand
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.
- S. H. Turner, R. Cherniak, E. Reiss
- Chemistry, Medicine
- Carbohydrate research
- 15 February 1984
Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.
- Y. Han, T. Kanbe, R. Cherniak, J. Cutler
- Biology, Medicine
- Infection and immunity
- 1 October 1997
We previously reported that the immunoglobulin M (IgM) monoclonal antibody (MAb) B6.1 protects mice against disseminated candidiasis, whereas the IgM MAb B6 does not. Both MAbs are specific for an… Expand